Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

16 Nov 2012 07:00

RNS Number : 2676R
Gleeson(M J)Group PLC
16 November 2012
 



Friday 16 November 2012

 

 

M J GLEESON GROUP PLC

 

INTERIM MANAGEMENT STATEMENT

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 July 2012 to 15 November 2012, in accordance with the UK Listing Authority's Disclosure and Transparency Rules.

 

Gleeson operates as the following divisions:

 

·; a housebuilder, mainly in the North of England, with a particular focus on low cost homes for local people;

 

·; a strategic land development business, mainly in the South of England, that enhances the value of land, principally held under option, through the planning process;

 

Gleeson Homes

 

Total sales, comprising reserved, contracted and completed homes, are up by 42% from a year ago.

 

Since the beginning of the period we have opened six new sites, two in each region. A total of 26 sites are currently open.

 

Prices for units being sold are in line with management's expectations at an average of £119,000. This is a decrease of £9,000 from the prior year due to a change in geographic mix. The proportion of units being sold on recently acquired higher margin sites has improved significantly since the prior year, with only 25% of total sales noted above from old, low margin sites, compared to 64% in the comparable period.

 

The housing market in the North of England remains challenging and weekly sales rates have on occasion fallen below expectations. Nonetheless, the division's very successful control of costs, coupled with the substantial increase in the number of new higher margin selling outlets, has meant that the overall level of sales achieved during the period will deliver a substantially improved level of profitability.

 

As previously reported, mortgage availability continues to remain restricted. However, we have seen a significant level of interest in the Government's FirstBuy scheme, which provides support to first time buyers by way of a 20% equity loan. In addition, Gleeson Homes is one of the first developers to have secured a low interest loan for site specific development from the Government's Get Britain Building Fund.

 

Five sites have been purchased during the period, which have added 331 plots to the Group's land bank. The Group is currently in discussions regarding the acquisition of a further 13 sites, which, if purchased, will add 1,082 plots to the land bank, taking the total number of plots to in excess of 3,700.

 

Gleeson Strategic Land

 

During the period, Gleeson Strategic Land has sold two significant sites and continues to replenish the portfolio, entering three new agreements since 1 July 2012, comprising 170 acres and, potentially, 1,000 plots.

 

The volume housebuilders continue to display a strong appetite for green field residential land in the South of England and Gleeson Strategic Land is experiencing a high level of interest in the sites which it hopes to bring to the market in the remainder of the year.

 

Outlook

 

The Board is encouraged by the achievements of both Gleeson Homes and Gleeson Strategic Land in challenging circumstances and remains confident that they are laying the foundations of a strong and sustainable improvement in the Group's performance.

 

 

 

 

 

 

Enquiries:

 

M J Gleeson Group plc 01252 360 300

 

Jolyon Harrison Chief Executive Officer

Alan Martin Chief Financial Officer

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMMMVKDGZZM
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.